AKR1B1 and chronic kidney disease: As shown in Figure 9A, according to degree > 4.8, five components (isopongaflavone, gossypetin, myricetin, quercetin, and liquiritin) and four targets (AKR1B1, PTGS2, CA2, and ALOX5) were key and may play an important role in treating CKD.